Diamonds and Dogs
11/12/13
Rackspace Hosting Inc. (RAX)Rackspace is trading in the red today, down 12.37% at $43.21. The cloud computing service company saw its shares fall after reporting mixed third quarter results. Revenues rose 16% to $388.6 million, which translated into a 40% drop in net income and an EPS of $0.11. Analysts were expecting the company to have revenue of $387.47 million, but also expected a higher EPS of $0.16. The lower net income is a direct result of management's capital expenditures, which CFO Karl Pichler stated were to make investments in equipment. Rackspace shares are still around $10 above their 52-week low of $33.91.
Vanda Pharmaceuticals Inc. (VNDA)
Vanda Pharmaceuticals is skyrocketing today,
up 95.79% $13.29. The biopharmaceutical company; which specializes on central nervous system disorders, popped after documents were posted on the FDA website that shined a light on Vanda's drug tasimelteon. The document stated that tasimelteon helps blind people sleep. Most people have no trouble staying on a normal sleep pattern as our bodies adjust to the sun and use that as our gauge of when to sleep. Blind people don't have this luxury, and thus have a difficult time maintaining normal sleep patterns, which tasimelteon hopes to cure. Vanda shares hit the daily double today when they reached a new 52-week high of $13.47 intraday.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.